ly 311727 has been researched along with 4-(2-aminoethyl)benzenesulfonylfluoride in 1 studies
| Studies (ly 311727) | Trials (ly 311727) | Recent Studies (post-2010) (ly 311727) | Studies (4-(2-aminoethyl)benzenesulfonylfluoride) | Trials (4-(2-aminoethyl)benzenesulfonylfluoride) | Recent Studies (post-2010) (4-(2-aminoethyl)benzenesulfonylfluoride) |
|---|---|---|---|---|---|
| 33 | 1 | 6 | 247 | 1 | 79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buitrago-Rey, R; Gomez-Marin, JE; Olarte, J | 1 |
1 other study(ies) available for ly 311727 and 4-(2-aminoethyl)benzenesulfonylfluoride
| Article | Year |
|---|---|
Evaluation of two inhibitors of invasion: LY311727 [3-(3-acetamide-1-benzyl-2-ethyl-indolyl-5-oxy)propane phosphonic acid] and AEBSF [4-(2-aminoethyl)-benzenesulphonyl fluoride] in acute murine toxoplasmosis.
Topics: Animals; Anti-Infective Agents; Indoles; Mice; Mice, Inbred ICR; Phospholipases A; Phospholipases A2; Structure-Activity Relationship; Sulfones; Survival Analysis; Toxoplasma; Toxoplasmosis | 2002 |